Thursday, 31 March 2016 09:16

BTS-9000

Written by
Rate this item
(0 votes)

BTS9000 is based on Neware 6th-generation testing system. It's designed for battery material research, high-precision tests, pulse charge/discharge tests, DCIR test, and cycle life test. 

As the most cutting-edge equipment for battery material research, BTS9000 comes with extremely high accuracy(±0.02% of FS), amazing hardware response speed(≤100μs), wide range of applications, high-speed testing data acquisition and many other industry-proven characteristics, it's your ultimate choice for battery material research!

It characterized with a data acquisition frequency up to 1000Hz, an accuracy of 0.02% FS and a minimum pulse width of 400us (microsecond) which can be utilized for GSM or some other rapid pulse tests. Comes to the pulse tests, BTS9000 supports GSM(Global System for Mobile Communications), GPRS(General Packet Radio Service), CDMA-standby, CDMA-talk(Code Division Multiple Access), IDEN(Integrated Digital Enhanced Networks), etc.

 

1.Resolution: AD: 16bit; DA: 16bit;

2.Accuracy : 0.02% FS;

3.Response Time: ≤100us (Current in the range 10%~90% FS);

4.Data Acquisition Frequency: 1000Hz;

5.Minimum Pulse Width: 400us;

6.Voltage Range: 5V;

7.Current Ranges: Range 1: 160uA ± 32nA

                                  Range 2: 5mA ± 1uA

                                  Range 3: 160mA ± 32uA

                                  Range 4: 5000mA ± 1mA

Read 80091 times Last modified on Friday, 18 November 2016 09:36

3540 comments

  • Comment Link canada pharmaceuticals Sunday, 24 August 2025 10:01 posted by canada pharmaceuticals

    Saved as a favorite, I love your web site!

  • Comment Link list of canadian pharmaceuticals online Sunday, 24 August 2025 09:23 posted by list of canadian pharmaceuticals online

    Hi there, its nice article about media print, we all be aware of media is a fantastic source of information.

  • Comment Link national pharmacies Sunday, 24 August 2025 08:45 posted by national pharmacies

    Very descriptive article, I loved that a lot. Will there be a part 2?

  • Comment Link canada pharmaceuticals online generic Sunday, 24 August 2025 08:06 posted by canada pharmaceuticals online generic

    Hi there! This is my first comment here so I just wanted to give a quick shout out and tell you I genuinely enjoy reading through your blog posts. Can you suggest any other blogs/websites/forums that go over the same subjects? Thanks a ton!

  • Comment Link pharmacy online shopping Sunday, 24 August 2025 07:29 posted by pharmacy online shopping

    I loved as much as you'll receive carried out right here. The sketch is attractive, your authored subject matter stylish. nonetheless, you command get got an impatience over that you wish be delivering the following. unwell unquestionably come more formerly again since exactly the same nearly a lot often inside case you shield this hike.

  • Comment Link navarro pharmacy miami Sunday, 24 August 2025 06:51 posted by navarro pharmacy miami

    Thank you for sharing your thoughts. I truly appreciate your efforts and I am waiting for your further post thank you once again.

  • Comment Link canadian pharmaceuticals Sunday, 24 August 2025 06:13 posted by canadian pharmaceuticals

    Very nice write-up. I certainly love this site. Keep writing!

  • Comment Link canadian pharmacy cialis 20mg Sunday, 24 August 2025 05:36 posted by canadian pharmacy cialis 20mg

    Amazing! Its in fact remarkable piece of writing, I have got much clear idea regarding from this article.

  • Comment Link canada pharmacy Sunday, 24 August 2025 04:58 posted by canada pharmacy

    This website was... how do I say it? Relevant!! Finally I've found something that helped me. Thanks a lot!

  • Comment Link pharmaceuticals online australia Sunday, 24 August 2025 04:21 posted by pharmaceuticals online australia

    This is a topic that's near to my heart... Many thanks! Where are your contact details though?

Leave a comment

Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.